Notas de prensa

  • 3 de enero de 2005
  • 178

Amgen Donates $1 Million and Establishes Tsunami Relief Program; Staff Donations, Company Contributions To Help South Asia Victims

THOUSAND OAKS, Calif., Jan 3, 2005 (BUSINESS WIRE) -- Amgen Inc. (Nasdaq:AMGN) today announced that it has established a company-wide South Asia Tsunami Relief Program and provided an initial cash contribution of $1 million in support of humanitarian aid to the International Federation of Red Cross and Red Crescent Societies.

Amgen has also launched an internal Web site to facilitate individual staff donations. Amgen staff contributions for tsunami relief efforts will be matched dollar for dollar.

The immediate $1 million corporate donation to the Red Cross will be used for relief efforts including support for field hospitals and delivery of emergency relief supplies.

"Amgen´s corporate contributions and individual donations are expressions of our sincere sympathy for those directly affected by this tragedy," said Kevin Sharer, Amgen´s chairman and chief executive officer.

Amgen´s matching gift program for this effort will remain open for at least six months to assist in long-term recovery efforts.

About Amgen

Amgen is a global biotechnology company that discovers, develops, manufactures and markets important human therapeutics based on advances in cellular and molecular biology.

SOURCE: Amgen

Amgen, Thousand OaksChristine Cassiano, 805-447-4587 (media) Arvind Sood, 805-447-1060 (investors)

Destacadas

  • XIV Curso de Cáncer Hereditario de SEOM

    Farmanews Farmanews

    XIV Curso de Cáncer Hereditario de SEOM

    Leer más
  • Nutricia lanza Fortimel Diabetcare Protein®, una novedosa fórmula para la recuperación nutricional de los pacientes con diabetes

    Alba Martín

    Nutricia lanza Fortimel Diabetcare Protein®, una novedosa fórmula para la recuperación nutricional de los pacientes con diabetes

    Leer más
  • 7 de cada 10 mujeres con enfermedades raras ha visto agravada su enfermedad a causa de un retraso en el diagnóstico

    Alba Martín

    7 de cada 10 mujeres con enfermedades raras ha visto agravada su enfermedad a causa de un retraso en el diagnóstico

    Leer más

Newsletter

Suscríbete para conocer las novedades del mundo farmacéutico y sanitario.

¿Qué es?

FarmaNews pone a disposición de los medios y departamentos de comunicación, un canal para publicar notas de prensa y convocatorias del mundo sanitario y farmacéutico.

Contacto

Avda. Mare de Déu de Lourdes, 108,
08757, Corbera de Llobregat
(Barcelona), España